优化循环利尿治疗以减少急性喘息患者的死亡率,使用实用离线强化学习管道为医疗保健:回顾性单中心模拟研究
Jung Min Lee1, Shengpu Tang1,2, Michael Sjoding3
1Division of Computer Science and Engineering, College of Engineering, University of Michigan, 2260 Hayward St, Ann Arbor, MI, 48109, United States, 1 7346474832.
JMIR medical informatics
|October 10, 2025
概括
线下强化学习 (RL) 的新管道改善了循环利尿剂的临床决策. 这种方法通过优化治疗政策与标准临床医生行为相比,显著降低了医院内死亡率.
科学领域:
- 临床信息学是一种临床信息学.
- 机器学习在医疗保健中的应用
- 强化学习应用程序的强化学习应用程序
背景情况:
- 离线强化学习 (RL) 越来越多地用于临床决策.
- 现有的方法缺乏标准化,导致过度配备的政策和不准确的评估.
- 需要一个强大的管道来提高可靠性和临床工作流集成.
研究的目的:
- 引入一个实用的管道,管道学习强化学习 (PROP-RL) 强化学习的强有力的政策,用于临床环境中的线下RL.
- 提高政策的稳定性,并尽量减少对临床工作流程的干扰.
- 证明在优化循环利尿剂治疗医院患者的有效性.
主要方法:
- 模拟循环利尿剂管理作为一个线下RL问题,使用电子健康记录数据.
- 定义了一个离散状态空间,二元动作空间 (利尿剂使用) 和医院死亡奖励函数.
- 训练并评估了大量成年住院患者的政策,与临床医生的行为进行比较.
主要成果:
- 这项研究包括36570例住院治疗.
- 学习政策与大多数州的临床医生一致,但在两个州有所分歧.
- 在分歧的情况下,RL政策显著降低了死亡率,从3.8%降至2.2% (1.6%的降低,P=.006).
结论:
- PROP-RL管道为顺序处理选择中的离线RL提供了一个强大的方法.
- 强调国家代表和政策评估在临床RL中的重要性.
- 确定当前循环利尿剂治疗策略的潜在改进,并为未来临床RL应用提供蓝图.
相关概念视频
Heart Failure V: Medical Management
218
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
218
Heart Failure Drugs: Diuretics
804
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
804
Heart Failure VI: Adjunct Therapies
255
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
255
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
932
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
932
Heart Failure Drugs: β-Blockers
770
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
770
Mitral Regurgitation IV: Nursing Management
307
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
307


